News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Missouri
Pharmacy benefit managers
Cigna to Remove AbbVie’s Humira From Formularies, Putting More Pressure on Blockbuster
Mirroring fellow pharmacy benefit manager CVS Caremark, Cigna’s Express Scripts is taking Humira off its major commercial formularies starting next year and focusing on more affordable biosimilar options.
August 27, 2024
·
2 min read
·
Tristan Manalac
PRESS RELEASES
Press Releases
Wugen to Present Correlative Data and Long-Term Follow-Up Updates for Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell therapy at the 2025 ASH Annual Meeting
December 5, 2025
·
4 min read
Press Releases
C2N Diagnostics Awarded Rigorous New York State Department of Health Permit, Expanding Ability to Provide Its Blood Tests to Help Diagnose Alzheimer’s Disease
November 24, 2025
·
4 min read
Press Releases
Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference
November 24, 2025
·
2 min read
Press Releases
Curium Consolidates New Biopharma Business and Sets Up Global Headquarters in Boston, Massachusetts
November 18, 2025
·
3 min read
Press Releases
Stereotaxis Reports 2025 Third Quarter Financial Results
November 11, 2025
·
9 min read
Press Releases
GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance
November 10, 2025
·
4 min read
Press Releases
Par Health Completes Spin-Off from Mallinckrodt, Creating an Independent Leader in Generic Pharmaceuticals and Sterile Injectables
November 10, 2025
·
7 min read
Press Releases
Par Health Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
19 min read
Press Releases
MediBeacon to Present at the Upcoming American Society of Nephrology (ASN) Kidney Week 2025
October 31, 2025
·
3 min read
Press Releases
CENTENE CORPORATION REPORTS THIRD QUARTER 2025 RESULTS
October 29, 2025
·
32 min read
Press Releases
Geneoscopy’s Scrape-Free Collection Method for Colorectal Cancer Screening Validated by New Data and Peer-Reviewed Publication
October 23, 2025
·
4 min read
Press Releases
MediBeacon receives regulatory approval to sell the Transdermal GFR System in China
October 22, 2025
·
5 min read
Press Releases
Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025
October 22, 2025
·
1 min read
Press Releases
Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs
October 16, 2025
·
4 min read
Press Releases
Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias
October 14, 2025
·
4 min read
Press Releases
Amplifi Vascular Announces Successful First-in-Human Study Results, Closes $6.8M Series A, and Receives FDA IDE Approval
October 9, 2025
·
2 min read
Press Releases
Biodexa to Host Breakfast Symposium on FAP Mechanisms and Chemoprevention Trial Issues at CGA – IGC Conference on October 11, 2025
October 7, 2025
·
5 min read
Press Releases
C2N Submits U.S. FDA Regulatory Filing for Its Alzheimer’s Disease Blood Test
October 2, 2025
·
5 min read
Press Releases
New Research Reinforces C2N’s PrecivityAD2™ Blood Test as a Highly Accurate Tool to Detect Brain Amyloid Pathology in Symptomatic Patients
September 25, 2025
·
4 min read
Press Releases
LPOXY Initiates $28M Series A Financing with 5 Horizons Ventures to Fund STOP-Cdiff Pivotal Trial
September 3, 2025
·
3 min read